Provided by Tiger Trade Technology Pte. Ltd.

Sinovac Biotech

6.47
0.0000
Volume:- -
Turnover:- -
Market Cap:388.59M
PE:-4.94
High:6.47
Open:6.47
Low:6.47
Close:6.47
52wk High:6.47
52wk Low:6.47
Shares:60.06M
Float Shares:31.17M
Volume Ratio:0.52
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.3100
EPS(LYR):1.06
ROE:25.15%
ROA:11.46%
PB:0.52
PE(LYR):6.13

Loading ...

NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 11:41 AM

Reuters
·
Yesterday

NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 11:20 AM

Reuters
·
Feb 20

NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM

Reuters
·
Feb 06

Sinovac Biotech Board Secures Interim Control Under Antigua Court Order Amid Governance Dispute

TIPRANKS
·
Jan 31

Sinovac Biotech Reshapes Board Committees and Forms Litigation Panel After August 19 Meeting

TIPRANKS
·
Jan 31

NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 10:06 AM

Reuters
·
Jan 26

NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 07:59 PM

Reuters
·
Jan 24

NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 10:59 AM

Reuters
·
Jan 22

Sinovac Biotech says Nasdaq hearings panel grants continued listing

TIPRANKS
·
Jan 22

BRIEF-Sinovac Announces Nasdaq Hearings Panel Grants Continued Listing

Reuters
·
Jan 22

NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 09:05 AM

Reuters
·
Jan 21

NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 11:45 AM

Reuters
·
Jan 16

NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 11:40 AM

Reuters
·
Jan 15

NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 09:48 AM

Reuters
·
Jan 12

NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:09 PM

Reuters
·
Jan 10

NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 02:55 PM

Reuters
·
Jan 09

Sinovac Biotech Gets Nasdaq Letter on Late Filing of Interim Income Statement

MT Newswires Live
·
Jan 05

Sinovac Provides Update on Antigua High Court Order and Auditor Engagement

THOMSON REUTERS
·
Jan 04

BRIEF-Sinovac Says Co Receives Nasdaq Notification Regarding Late Filing Of 2025 Half-Year Report

Reuters
·
Jan 04

Sinovac Biotech Ltd - Receives Nasdaq Notification Letter Dated January 2, 2026

THOMSON REUTERS
·
Jan 04